Backed by Eli Cas­din, a DNA syn­the­sis com­pa­ny gets a big Se­ries C ahead of its first prod­uct launch

An Eli Cas­din-backed com­pa­ny look­ing to shake up the busi­ness of DNA print­ing clinched a nine-fig­ure raise to get its first prod­uct off the ground.

DNA Script closed its $165 mil­lion Se­ries C on Tues­day morn­ing, the com­pa­ny an­nounced, giv­ing it a new cash reser­voir as it pre­pares the first prod­uct launch in the sec­ond half of next year. It’s a move that comes about 15 months af­ter its last fundraise, when DNA Script net­ted a $50 mil­lion Se­ries B in Ju­ly 2020.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER